Browse > Article
http://dx.doi.org/10.7778/jpkm.2021.35.4.48

Inflammation Relief Effect through ECS Control of Galgeunhwanggeumhwangryeon-tang Extract in Atopic Dermatitis  

Kim, Ki Bong (School of Korean Medicine, Pusan National University)
Ahn, Sang Hyun (Dept. of anatomy, college of Korean Medicine, Semyung University)
Publication Information
The Journal of Pediatrics of Korean Medicine / v.35, no.4, 2021 , pp. 48-55 More about this Journal
Abstract
Objective The purpose of this study was to confirm the effects of Galgeunhwanggeumhwangryeon-tang in reducing inflammation through the endocannabinoid system (ECS) control in atopic dermatitis. Methods 8-week-old Balb/C mice were divided into 4 groups: contorl group (Ctrl), lipid barrier elimination group (ADE), palmitoylethanolamide treated group after lipid barrier elimination (PEA), and Galgeunhwanggeumhwangryeon-tang applied group after lipid barrier elimination (GGRT). After inducing atopic dermatitis, cannabinoid receptor (CB) 1, CB2, CD68, phosphorylated inhibitor kappa B (p-IκB), inducible nitric oxide synthase (iNOS), substance P and serotonin were observed to confirm the regulation of the ECS, macrophage activity and mast cell activity. Results CB1 and CB2 showed higher positive reactions in the GGRT than in the LBE and PEA. CD68, p-IκB and iNOS showed higher positive reaction in the LBE, PEA and GGRT than in the Ctrl, but the increase in the positive reaction was lower in the GGRT compared to the LBE and PEA. Substance P and serotonin showed higher positive reaction in the LBE, PEA and GGRT than in the Ctrl, but the increase in the positive reaction was lower in the GGRT compared to the LBE and PEA. Conclusions The effects of Galgeunhwanggeumhwangryeon-tang were confirmed though the regulation of the ECS, macrophage activity and mast cell activity.
Keywords
Galgeunhwanggeumhwangryeon-tang; Atopic Dermatitis; Endocannabinoid system (ECS); cannabinoid receptor 1 (CB1); cannabinoid receptor 2 (CB2); Mast cell;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ahn KM, Kim JH, Kwon HJ, Chae YM, Hahm MI, Lee KJ, Park YM, Lee SY, Han MY, Kim WK. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011;54(7):769-78.   DOI
2 Kim MJ, Lee SY. A literature study of atopic dermatitis for children. J Pediatr Korean Med. 2000;14(2):167-82.
3 Kim HB, Kang KH, Hwang WD, Lyu SA, Lee SY. The effects of Puerariae Radix on allergic inflammation. J Korean Oriental Pediatrics. 2009;23(3):217-31.
4 Toth BI, Dobrosi N, Dajnoki A, Czifra G, Olah A, Szollosi AG, Juhasz I, Sugawara K, Paus R, Biro T. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol. 2011;131(5):1095-104.   DOI
5 Toth KF, Adam D, Biro T, Olah A. Cannabinoid signaling in the skin: therapeutic potential of the "C(ut)annabinoid" system. Molecules. 2019;24(5):918.   DOI
6 Chung, HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18-30.   DOI
7 Chin LW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, Chou MC, Yang CC. Anti-herpes simplex virus effects of berberine from Coptidis Rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol 2010;155(12):1933-41.   DOI
8 Baron ED, Barzilai D, Johnston G, Kawashima M, Takigawa M, Nakagawa H, Graham-Browh R. Stevens SR. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K. Br J Dermatol. 2002;147:710-5.   DOI
9 Ahn SH, Kim KB. Effect of anti-inflammation through creation of skin fat barrier on Scutellaria baicalensis extract. J Pediatr Korean Med. 2021;35(1):40-7.   DOI
10 Kim YH, Park YS. Effect of Scutellaria baicalensis water extract on antioxidative activity and epidermal thickness in DNCB-induced allergic contact dermatitis animal model. Korean Soc Food Sci Nutr. 2006;35(5):543-8.   DOI
11 Kim HK, Hong SU. The anti-inflammatory effects of Huang-Lyun (Coptidis Rhizoma, CR) on injured tissue after burn elicitation. J Korean Oriental Med. 2011;32(2):1-13.
12 Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med. 2002;30(1) Suppl:s74-9.   DOI
13 Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87(1):13-20.   DOI
14 Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344(1):30-7.   DOI
15 Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol. 2005;168:509-54.   DOI
16 Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462.   DOI
17 Kupczyk P, Reich A, Szepietowski JC. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol. 2009;18(8):669-79.   DOI
18 Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science. 2007; 316(5830):1494-97.   DOI
19 Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol. 2007;152(5):624-32.   DOI
20 Kim JH. Current understanding of atopic dermatitis. Pediatr Allergy Respir Dis. 2004;14(1):12-23.
21 Yang BD, Kim SR, Choi CH, Jeoung HW, Kim HW. Effects of Scutellaria baicalensis extract on skin lesion of contact dermatitis induced by DNFB in Mice. J Physiol & Pathol Korean Med. 2017;31(1):59-64.   DOI
22 Luger TA. Neuromediators--a crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87-93.   DOI
23 Maccarrone M, Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A. The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem. 2003;278(36):33896-903.   DOI
24 Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 2003;111(1):43-50.   DOI
25 Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England). 2016;387(10023):1109-22.   DOI
26 7. Muluye RA, Bian Y, Alemu PN. Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. J Tradit Complement Med. 2014;4(2):93-8.   DOI
27 Yu YE, Park EY, Jung DH, Byun SH, Kim SC, Park SM. Antibacterial activity of oriental medicinal herb extracts against skin pathogens. J Life Sci. 2010;20(7):1143-50.   DOI
28 Salzet M. Invertebrate molecular neuroimmune processes. Brain Res Rev, 2000;34(1):69-79.   DOI
29 Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev. 2011;63(3): 461-70.   DOI
30 Lee JY, Kim DG. The clinical study of atopic dermatitis. J Pediatr Korean Med. 1999;13(2):171-86.
31 Jee HM, Kim KW, Kim CS, Sohn MH, Shin DC, Kim KE. Prevalence of asthma, rhinitis and eczema in Korean children using the international study of asthma and allergies in childhood (ISAAC) questionnaires. Pediatr Allergy Respir Dis. 2009;19(2):165-72.
32 Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sciences. 2004;75(6):639-53.   DOI